Chronic restraint stress impairs endocannabinoid mediated suppression of GABAergic signaling in the hippocampus of adult male rats

Brain Research Bulletin

Volumn 85, Issue 6, 2011, Pages 374-379

  Hu, Wen ^a   Zhang, Mingyue ^c   Czéh, Boldizsár ^a   Zhang, Weiqi ^c   Flügge, Gabriele ^a,b  

^a GERMAN PRIMATE CENTER   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Chronic stress; DSI; Endocannabinoid; GABA; Neuroplasticity

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR ANTAGONIST; CARBACHOL; CHOLECYSTOKININ; ENDOCANNABINOID; STRYCHNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC RESTRAINT STRESS; CHRONIC STRESS; COGNITIVE DEFECT; CONTROLLED STUDY; DEPOLARIZATION; DEPOLARIZATION INDUCED SUPPRESSION OF INHIBITION; GABAERGIC TRANSMISSION; HIPPOCAMPUS; IMMOBILIZATION STRESS; INFORMATION PROCESSING; INHIBITORY POSTSYNAPTIC POTENTIAL; INTERNEURON; MALE; MENTAL STRESS; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; SIGNAL TRANSDUCTION; VOLTAGE CLAMP; WHOLE CELL;

ANIMALS; BODY WEIGHT; ENDOCANNABINOIDS; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; INTERNEURONS; MALE; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RESTRAINT, PHYSICAL; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL;

EID: 79960198506     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2011.04.005     Document Type: Article

References (31)

1. Buzsaki G., Draguhn A. Neuronal oscillations in cortical networks. Science 2004, 304:1926-1929.
2. Campolongo P., Roozendaal B., Trezza V., Hauer D., Schelling G., McGaugh J.L., Cuomo V. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:4888-4893.
3. Carlson G., Wang Y., Alger B.E. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 2002, 5:723-724.
4. Di S., Malcher-Lopes R., Marcheselli V.L., Bazan N.G., Tasker J.G. Rapid glucocorticoid-mediated endocannabinoid release and opposing regulation of glutamate and gamma-aminobutyric acid inputs to hypothalamic magnocellular neurons. Endocrinology 2005, 146:4292-4301.
5. Domenici M.R., Azad S.C., Marsicano G., Schierloh A., Wotjak C.T., Dodt H.U., Zieglgänsberger W., Lutz B., Rammes G. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J. Neurosci. 2006, 26:5794-5799.
6. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct. Funct. 2008, 213:93-118.
7. Fride E., Suris R., Weidenfeld J., Mechoulam R. Differential response to acute and repeated stress in cannabinoid CB1 receptor knockout newborn and adult mice. Behav. Pharmacol. 2005, 16:431-440.
8. Hajos N., Katona I., Naiem S.S., MacKie K., Ledent C., Mody I., Freund T.F. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur. J. Neurosci. 2000, 12:3239-3249.
9. Hill M.N., Carrier E.J., Ho W.S., Shi L., Patel S., Gorzalka B.B., Hillard C.J. Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus. Hippocampus 2008, 18:221-226.
10. Hill M.N., Hunter R.G., McEwen B.S. Chronic stress differentially regulates cannabinoid CB1 receptor binding in distinct hippocampal subfields. Eur. J. Pharmacol. 2009, 614:66-69.
11. Hill M.N., McLaughlin R.J., Bingham B., Shrestha L., Lee T.T., Gray J.M., Hillard C.J., Gorzalka B.B., Viau V. Endogenous cannabinoid signaling is essential for stress adaptation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9406-9411.
12. Hill M.N., Patel S., Carrier E.J., Rademacher D.J., Ormerod B.K., Hillard C.J., Gorzalka B.B. Downregulation of endocannabinoid signaling in the hippocampus following chronic unpredictable stress. Neuropsychopharmacology 2005, 30:508-515.
13. Hu W., Zhang M., Czeh B., Flugge G., Zhang W. Stress impairs GABAergic network function in the hippocampus by activating nongenomic glucocorticoid receptors and affecting the integrity of the parvalbumin-expressing neuronal network. Neuropsychopharmacology 2010, 35:1693-1707.
14. Juhasz G., Chase D., Pegg E., Downey D., Toth Z.G., Stones K., Platt H., Mekli K., Payton A., Elliott R., Anderson I.M., Deakin J.F. CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms. Neuropsychopharmacology 2009, 34:2019-2027.
15. Karson M.A., Whittington K.C., Alger B.E. Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others. Neuropharmacology 2008, 54:117-128.
16. Kawamura Y., Fukaya M., Maejima T., Yoshida T., Miura E., Watanabe M., Ohno-Shosaku T., Kano M. The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J. Neurosci. 2006, 26:2991-3001.
17. Magarinos A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 1995, 69:89-98.
18. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
19. McLaughlin K.J., Gomez J.L., Baran S.E., Conrad C.D. The effects of chronic stress on hippocampal morphology and function: an evaluation of chronic restraint paradigms. Brain Res. 2007, 1161:56-64.
20. Nemeth B., Ledent C., Freund T.F., Hajos N. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2. Neuropharmacology 2008, 54:51-57.
21. Patel S., Kingsley P.J., Mackie K., Marnett L.J., Winder D.G. Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. Neuropsychopharmacology 2009, 34:2699-2709.
22. Patel S., Roelke C.T., Rademacher D.J., Hillard C.J. Inhibition of restraint stress-induced neural and behavioural activation by endogenous cannabinoid signalling. Eur. J. Neurosci. 2005, 21:1057-1069.
23. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
24. Rademacher D.J., Meier S.E., Shi L., Ho W.S., Jarrahian A., Hillard C.J. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 2008, 54:108-116.
25. Reich C.G., Karson M.A., Karnup S.V., Jones L.M., Alger B.E. Regulation of IPSP theta rhythm by muscarinic receptors and endocannabinoids in hippocampus. J. Neurophysiol. 2005, 94:4290-4299.
26. Reich C.G., Taylor M.E., McCarthy M.M. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav. Brain Res. 2009, 203:264-269.
27. Rossi S., De Chiara V., Musella A., Kusayanagi H., Mataluni G., Bernardi G., Usiello A., Centonze D. Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. J. Neurosci. 2008, 28:7284-7292.
28. Somogyi P., Klausberger T. Defined types of cortical interneurone structure space and spike timing in the hippocampus. J. Physiol. 2005, 562:9-26.
29. Steiner M.A., Marsicano G., Nestler E.J., Holsboer F., Lutz B., Wotjak C.T. Antidepressant-like behavioral effects of impaired cannabinoid receptor type 1 signaling coincide with exaggerated corticosterone secretion in mice. Psychoneuroendocrinology 2008, 33:54-67.
30. Steiner M.A., Wanisch K., Monory K., Marsicano G., Borroni E., Bachli H., Holsboer F., Lutz B., Wotjak C.T. Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice. Pharmacogenomics J. 2008, 8:196-208.
31. Wamsteeker J.I., Kuzmiski J.B., Bains J.S. Repeated stress impairs endocannabinoid signaling in the paraventricular nucleus of the hypothalamus. J. Neurosci. 2010, 30:11188-11196.